ID   MCE1_HUMAN              Reviewed;         597 AA.
AC   O60942; E1P513; E1P514; O43483; O60257; O60351; Q5TCW8; Q8WUM8;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1998, sequence version 1.
DT   15-MAR-2017, entry version 168.
DE   RecName: Full=mRNA-capping enzyme;
DE   AltName: Full=HCAP1;
DE   AltName: Full=HCE;
DE   Includes:
DE     RecName: Full=Polynucleotide 5'-triphosphatase;
DE              EC=3.1.3.33;
DE     AltName: Full=mRNA 5'-triphosphatase;
DE              Short=TPase;
DE   Includes:
DE     RecName: Full=mRNA guanylyltransferase;
DE              EC=2.7.7.50;
DE     AltName: Full=GTP--RNA guanylyltransferase;
DE              Short=GTase;
GN   Name=RNGTT; Synonyms=CAP1A;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=9371772; DOI=10.1073/pnas.94.24.12898;
RA   Yue Z., Maldonado E., Pillutla R., Cho H., Reinberg D., Shatkin A.J.;
RT   "Mammalian capping enzyme complements mutant Saccharomyces cerevisiae
RT   lacking mRNA guanylyltransferase and selectively binds the elongating
RT   form of RNA polymerase II.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:12898-12903(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), MUTAGENESIS OF
RP   LYS-294; ARG-299; GLU-345; LYS-458 AND LYS-460, AND FUNCTION.
RX   PubMed=9512541; DOI=10.1093/nar/26.7.1700;
RA   Yamada-Okabe T., Doi R., Shimmi O., Arisawa M., Yamada-Okabe H.;
RT   "Isolation and characterization of a human cDNA for mRNA 5'-capping
RT   enzyme.";
RL   Nucleic Acids Res. 26:1700-1706(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 4), FUNCTION, AND CATALYTIC
RP   ACTIVITY.
RC   TISSUE=Colon adenocarcinoma;
RX   PubMed=9473487; DOI=10.1006/bbrc.1997.8038;
RA   Tsukamoto T., Shibagaki Y., Murakoshi T., Suzuki M., Nakamura A.,
RA   Gotoh H., Mizumoto K.;
RT   "Cloning and characterization of two human cDNAs encoding the mRNA
RT   capping enzyme.";
RL   Biochem. Biophys. Res. Commun. 243:101-108(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT HIS-594.
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH RNMT.
RX   PubMed=9705270; DOI=10.1074/jbc.273.34.21443;
RA   Pillutla R.C., Yue Z., Maldonado E., Shatkin A.J.;
RT   "Recombinant human mRNA cap methyltransferase binds capping enzyme/RNA
RT   polymerase IIo complexes.";
RL   J. Biol. Chem. 273:21443-21446(1998).
RN   [8]
RP   INTERACTION WITH SUPT5H.
RX   PubMed=10421630; DOI=10.1101/gad.13.14.1774;
RA   Wen Y., Shatkin A.J.;
RT   "Transcription elongation factor hSPT5 stimulates mRNA capping.";
RL   Genes Dev. 13:1774-1779(1999).
RN   [9]
RP   INTERACTION WITH HIV-1 TAT.
RX   PubMed=11278368; DOI=10.1074/jbc.M007901200;
RA   Chiu Y.-L., Coronel E., Ho C.K., Shuman S., Rana T.M.;
RT   "HIV-1 Tat protein interacts with mammalian capping enzyme and
RT   stimulates capping of TAR RNA.";
RL   J. Biol. Chem. 276:12959-12966(2001).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 229-567, CATALYTIC ACTIVITY,
RP   FUNCTION, MUTAGENESIS OF GLU-234; LYS-458; LYS-460; ARG-528; ARG-530;
RP   ASP-532 AND LYS-533, AND ACTIVE SITE.
RX   PubMed=21636784; DOI=10.1073/pnas.1106610108;
RA   Chu C., Das K., Tyminski J.R., Bauman J.D., Guan R., Qiu W.,
RA   Montelione G.T., Arnold E., Shatkin A.J.;
RT   "Structure of the guanylyltransferase domain of human mRNA capping
RT   enzyme.";
RL   Proc. Natl. Acad. Sci. U.S.A. 108:10104-10108(2011).
CC   -!- FUNCTION: Bifunctional mRNA-capping enzyme exhibiting RNA 5'-
CC       triphosphatase activity in the N-terminal part and mRNA
CC       guanylyltransferase activity in the C-terminal part. Catalyzes the
CC       first two steps of cap formation: by removing the gamma-phosphate
CC       from the 5'-triphosphate end of nascent mRNA to yield a
CC       diphosphate end, and by transferring the gmp moiety of GTP to the
CC       5'-diphosphate terminus. {ECO:0000269|PubMed:21636784,
CC       ECO:0000269|PubMed:9473487, ECO:0000269|PubMed:9512541}.
CC   -!- CATALYTIC ACTIVITY: A 5'-phosphopolynucleotide + H(2)O = a
CC       polynucleotide + phosphate.
CC   -!- CATALYTIC ACTIVITY: GTP + (5')pp-Pur-mRNA = diphosphate +
CC       G(5')ppp-Pur-mRNA.
CC   -!- SUBUNIT: Interacts with POLR2A (via C-terminus); this enhances
CC       guanylyltransferase activity. Binds (via GTase domain) to the
CC       elongating phosphorylated form of RNA polymerase II; can form
CC       direct interactions with the phosphorylated POLR2A C-terminal
CC       domain and indirect interactions via bound RNA (By similarity).
CC       Interacts with SUPT5H and RNMT. Interacts with HIV-1 Tat.
CC       {ECO:0000250, ECO:0000269|PubMed:10421630,
CC       ECO:0000269|PubMed:11278368, ECO:0000269|PubMed:9705270}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=HCE1, HCAP1A;
CC         IsoId=O60942-1; Sequence=Displayed;
CC       Name=2; Synonyms=HCE1A;
CC         IsoId=O60942-2; Sequence=VSP_003202;
CC       Name=3; Synonyms=HCE1B;
CC         IsoId=O60942-3; Sequence=VSP_003202, VSP_003203;
CC       Name=4; Synonyms=HCAP1B;
CC         IsoId=O60942-4; Sequence=VSP_003204;
CC   -!- TISSUE SPECIFICITY: Isoform 1 and isoform 4 (at a lesser extent)
CC       are expressed in cerebrum, cerebellum, thyroid, lung, heart,
CC       liver, kidney, spleen, large intestine, testis, skin and muscle.
CC   -!- MISCELLANEOUS: Isoform 2 to isoform 4 lack mRNA 5'-
CC       guanylyltransferase activity due to disruptions of the GTase
CC       domain.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the non-receptor
CC       class of the protein-tyrosine phosphatase family. {ECO:0000305}.
CC   -!- SIMILARITY: In the C-terminal section; belongs to the eukaryotic
CC       GTase family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF025654; AAB91559.1; -; mRNA.
DR   EMBL; AB009022; BAA25894.1; -; mRNA.
DR   EMBL; AB009023; BAA25895.1; -; mRNA.
DR   EMBL; AB009024; BAA25896.1; -; mRNA.
DR   EMBL; AB012142; BAA25198.1; -; mRNA.
DR   EMBL; AB012143; BAA25199.1; -; mRNA.
DR   EMBL; AL079342; CAI22537.1; -; Genomic_DNA.
DR   EMBL; AL096868; CAI22537.1; JOINED; Genomic_DNA.
DR   EMBL; AL133408; CAI22537.1; JOINED; Genomic_DNA.
DR   EMBL; AL445530; CAI22537.1; JOINED; Genomic_DNA.
DR   EMBL; AL096868; CAI21547.1; -; Genomic_DNA.
DR   EMBL; AL079342; CAI21547.1; JOINED; Genomic_DNA.
DR   EMBL; AL133408; CAI21547.1; JOINED; Genomic_DNA.
DR   EMBL; AL445530; CAI21547.1; JOINED; Genomic_DNA.
DR   EMBL; AL133408; CAI21542.1; -; Genomic_DNA.
DR   EMBL; AL079342; CAI21542.1; JOINED; Genomic_DNA.
DR   EMBL; AL096868; CAI21542.1; JOINED; Genomic_DNA.
DR   EMBL; AL445530; CAI21542.1; JOINED; Genomic_DNA.
DR   EMBL; AL445530; CAI22048.1; -; Genomic_DNA.
DR   EMBL; AL079342; CAI22048.1; JOINED; Genomic_DNA.
DR   EMBL; AL096868; CAI22048.1; JOINED; Genomic_DNA.
DR   EMBL; AL133408; CAI22048.1; JOINED; Genomic_DNA.
DR   EMBL; CH471051; EAW48566.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48567.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48569.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW48570.1; -; Genomic_DNA.
DR   EMBL; BC019954; AAH19954.1; -; mRNA.
DR   CCDS; CCDS5017.1; -. [O60942-1]
DR   CCDS; CCDS69153.1; -. [O60942-2]
DR   PIR; JC5936; JC5936.
DR   PIR; JC5937; JC5937.
DR   RefSeq; NP_001273355.1; NM_001286426.1. [O60942-2]
DR   RefSeq; NP_001273357.1; NM_001286428.1.
DR   RefSeq; NP_003791.3; NM_003800.4. [O60942-1]
DR   UniGene; Hs.567378; -.
DR   UniGene; Hs.627135; -.
DR   PDB; 2C46; X-ray; 1.60 A; A/B/C/D=1-219.
DR   PDB; 3S24; X-ray; 3.01 A; A/B/C/D/E/F/G=229-567.
DR   PDBsum; 2C46; -.
DR   PDBsum; 3S24; -.
DR   ProteinModelPortal; O60942; -.
DR   SMR; O60942; -.
DR   BioGrid; 114270; 12.
DR   DIP; DIP-61014N; -.
DR   IntAct; O60942; 4.
DR   STRING; 9606.ENSP00000358497; -.
DR   DrugBank; DB02325; Isopropyl Alcohol.
DR   DEPOD; O60942; -.
DR   iPTMnet; O60942; -.
DR   PhosphoSitePlus; O60942; -.
DR   BioMuta; RNGTT; -.
DR   EPD; O60942; -.
DR   MaxQB; O60942; -.
DR   PaxDb; O60942; -.
DR   PeptideAtlas; O60942; -.
DR   PRIDE; O60942; -.
DR   DNASU; 8732; -.
DR   Ensembl; ENST00000369475; ENSP00000358487; ENSG00000111880. [O60942-2]
DR   Ensembl; ENST00000369485; ENSP00000358497; ENSG00000111880. [O60942-1]
DR   Ensembl; ENST00000538899; ENSP00000442609; ENSG00000111880. [O60942-3]
DR   GeneID; 8732; -.
DR   KEGG; hsa:8732; -.
DR   UCSC; uc003pmr.4; human. [O60942-1]
DR   CTD; 8732; -.
DR   DisGeNET; 8732; -.
DR   GeneCards; RNGTT; -.
DR   HGNC; HGNC:10073; RNGTT.
DR   HPA; HPA003750; -.
DR   MIM; 603512; gene.
DR   neXtProt; NX_O60942; -.
DR   OpenTargets; ENSG00000111880; -.
DR   PharmGKB; PA34446; -.
DR   eggNOG; KOG2386; Eukaryota.
DR   eggNOG; COG5226; LUCA.
DR   GeneTree; ENSGT00530000063473; -.
DR   HOVERGEN; HBG006332; -.
DR   InParanoid; O60942; -.
DR   KO; K13917; -.
DR   OMA; RFNERSP; -.
DR   OrthoDB; EOG091G063D; -.
DR   PhylomeDB; O60942; -.
DR   TreeFam; TF314914; -.
DR   BioCyc; MetaCyc:HS03479-MONOMER; -.
DR   BRENDA; 2.7.7.50; 2681.
DR   Reactome; R-HSA-167160; RNA Pol II CTD phosphorylation and interaction with CE during HIV infection.
DR   Reactome; R-HSA-72086; mRNA Capping.
DR   Reactome; R-HSA-77075; RNA Pol II CTD phosphorylation and interaction with CE.
DR   ChiTaRS; RNGTT; human.
DR   EvolutionaryTrace; O60942; -.
DR   GeneWiki; RNGTT; -.
DR   GenomeRNAi; 8732; -.
DR   PRO; PR:O60942; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000111880; -.
DR   CleanEx; HS_RNGTT; -.
DR   Genevisible; O60942; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004484; F:mRNA guanylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004651; F:polynucleotide 5'-phosphatase activity; TAS:Reactome.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:InterPro.
DR   GO; GO:0008138; F:protein tyrosine/serine/threonine phosphatase activity; IEA:InterPro.
DR   GO; GO:0008192; F:RNA guanylyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0050355; F:triphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0006370; P:7-methylguanosine mRNA capping; IDA:UniProtKB.
DR   GO; GO:0006396; P:RNA processing; IDA:UniProtKB.
DR   GO; GO:0006366; P:transcription from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.90.190.10; -; 1.
DR   InterPro; IPR000340; Dual-sp_phosphatase_cat-dom.
DR   InterPro; IPR017074; mRNA_cap_enz_bifunc.
DR   InterPro; IPR001339; mRNA_cap_enzyme.
DR   InterPro; IPR013846; mRNA_cap_enzyme_C.
DR   InterPro; IPR012340; NA-bd_OB-fold.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00782; DSPc; 1.
DR   Pfam; PF03919; mRNA_cap_C; 1.
DR   Pfam; PF01331; mRNA_cap_enzyme; 1.
DR   PIRSF; PIRSF036958; mRNA_capping_HCE; 1.
DR   SUPFAM; SSF50249; SSF50249; 1.
DR   SUPFAM; SSF52799; SSF52799; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 1.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Complete proteome; GTP-binding;
KW   Host-virus interaction; Hydrolase; mRNA capping; mRNA processing;
KW   Multifunctional enzyme; Nucleotide-binding; Nucleotidyltransferase;
KW   Nucleus; Polymorphism; Reference proteome; Transferase.
FT   CHAIN         1    597       mRNA-capping enzyme.
FT                                /FTId=PRO_0000210108.
FT   NP_BIND     343    345       GTP. {ECO:0000255}.
FT   NP_BIND     458    460       GTP. {ECO:0000255}.
FT   NP_BIND     528    533       GTP. {ECO:0000255}.
FT   REGION        1    212       TPase.
FT   REGION      229    597       GTase.
FT   REGION      330    386       Interaction with POLR2A. {ECO:0000250}.
FT   COMPBIAS    195    205       Asp/Glu-rich.
FT   ACT_SITE    126    126       For RNA 5'-triphosphatase activity.
FT                                {ECO:0000250}.
FT   ACT_SITE    294    294       N6-GMP-lysine intermediate.
FT                                {ECO:0000269|PubMed:21636784}.
FT   BINDING     299    299       GTP. {ECO:0000250}.
FT   BINDING     315    315       GTP. {ECO:0000255}.
FT   VAR_SEQ     424    446       Missing (in isoform 2 and isoform 3).
FT                                {ECO:0000303|PubMed:9512541}.
FT                                /FTId=VSP_003202.
FT   VAR_SEQ     481    597       Missing (in isoform 3).
FT                                {ECO:0000303|PubMed:9512541}.
FT                                /FTId=VSP_003203.
FT   VAR_SEQ     504    597       TKELKQYDNKIIECKFENNSWVFMRQRTDKSFPNAYNTAMA
FT                                VCNSISNPVTKEMLFEFIDRCTAASQGQKRKHHLDPDTELM
FT                                PPPPPKRPRPLT -> CLFIFSVLFLDVLLSGIHQNLANNN
FT                                QHIKISCSSTLGG (in isoform 4).
FT                                {ECO:0000303|PubMed:9473487}.
FT                                /FTId=VSP_003204.
FT   VARIANT     594    594       R -> H (in dbSNP:rs17856595).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_046481.
FT   MUTAGEN     234    234       E->A: No effect on GTase activity.
FT                                {ECO:0000269|PubMed:21636784}.
FT   MUTAGEN     294    294       K->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:9512541}.
FT   MUTAGEN     299    299       R->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:9512541}.
FT   MUTAGEN     345    345       E->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:9512541}.
FT   MUTAGEN     458    458       K->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:21636784,
FT                                ECO:0000269|PubMed:9512541}.
FT   MUTAGEN     460    460       K->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:21636784,
FT                                ECO:0000269|PubMed:9512541}.
FT   MUTAGEN     528    528       R->A: Strongly reduced GTase activity.
FT                                {ECO:0000269|PubMed:21636784}.
FT   MUTAGEN     530    530       R->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:21636784}.
FT   MUTAGEN     532    532       D->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:21636784}.
FT   MUTAGEN     533    533       K->A: Loss of GTase activity.
FT                                {ECO:0000269|PubMed:21636784}.
FT   CONFLICT     30     30       M -> I (in Ref. 1; AAB91559).
FT                                {ECO:0000305}.
FT   CONFLICT    212    212       P -> T (in Ref. 6; AAH19954).
FT                                {ECO:0000305}.
FT   CONFLICT    484    484       Q -> P (in Ref. 1; AAB91559).
FT                                {ECO:0000305}.
FT   TURN         21     23       {ECO:0000244|PDB:2C46}.
FT   STRAND       24     27       {ECO:0000244|PDB:2C46}.
FT   HELIX        33     38       {ECO:0000244|PDB:2C46}.
FT   HELIX        41     43       {ECO:0000244|PDB:2C46}.
FT   HELIX        47     57       {ECO:0000244|PDB:2C46}.
FT   STRAND       60     66       {ECO:0000244|PDB:2C46}.
FT   HELIX        77     80       {ECO:0000244|PDB:2C46}.
FT   TURN         81     83       {ECO:0000244|PDB:2C46}.
FT   STRAND       85     88       {ECO:0000244|PDB:2C46}.
FT   HELIX       100    110       {ECO:0000244|PDB:2C46}.
FT   STRAND      120    125       {ECO:0000244|PDB:2C46}.
FT   STRAND      127    130       {ECO:0000244|PDB:2C46}.
FT   HELIX       131    143       {ECO:0000244|PDB:2C46}.
FT   HELIX       149    159       {ECO:0000244|PDB:2C46}.
FT   HELIX       167    177       {ECO:0000244|PDB:2C46}.
FT   HELIX       180    182       {ECO:0000244|PDB:2C46}.
FT   STRAND      232    235       {ECO:0000244|PDB:3S24}.
FT   STRAND      241    243       {ECO:0000244|PDB:3S24}.
FT   HELIX       247    261       {ECO:0000244|PDB:3S24}.
FT   STRAND      265    267       {ECO:0000244|PDB:3S24}.
FT   STRAND      270    275       {ECO:0000244|PDB:3S24}.
FT   TURN        278    280       {ECO:0000244|PDB:3S24}.
FT   HELIX       281    285       {ECO:0000244|PDB:3S24}.
FT   STRAND      289    295       {ECO:0000244|PDB:3S24}.
FT   STRAND      298    304       {ECO:0000244|PDB:3S24}.
FT   STRAND      306    308       {ECO:0000244|PDB:3S24}.
FT   STRAND      310    314       {ECO:0000244|PDB:3S24}.
FT   STRAND      319    324       {ECO:0000244|PDB:3S24}.
FT   STRAND      339    351       {ECO:0000244|PDB:3S24}.
FT   STRAND      354    367       {ECO:0000244|PDB:3S24}.
FT   HELIX       372    374       {ECO:0000244|PDB:3S24}.
FT   HELIX       377    387       {ECO:0000244|PDB:3S24}.
FT   HELIX       389    394       {ECO:0000244|PDB:3S24}.
FT   TURN        395    397       {ECO:0000244|PDB:3S24}.
FT   STRAND      398    401       {ECO:0000244|PDB:3S24}.
FT   TURN        403    405       {ECO:0000244|PDB:3S24}.
FT   STRAND      406    412       {ECO:0000244|PDB:3S24}.
FT   HELIX       418    424       {ECO:0000244|PDB:3S24}.
FT   STRAND      437    446       {ECO:0000244|PDB:3S24}.
FT   STRAND      451    459       {ECO:0000244|PDB:3S24}.
FT   HELIX       462    464       {ECO:0000244|PDB:3S24}.
FT   STRAND      466    476       {ECO:0000244|PDB:3S24}.
FT   STRAND      484    490       {ECO:0000244|PDB:3S24}.
FT   STRAND      498    501       {ECO:0000244|PDB:3S24}.
FT   HELIX       507    509       {ECO:0000244|PDB:3S24}.
FT   STRAND      512    520       {ECO:0000244|PDB:3S24}.
FT   STRAND      523    529       {ECO:0000244|PDB:3S24}.
FT   HELIX       539    550       {ECO:0000244|PDB:3S24}.
FT   HELIX       555    563       {ECO:0000244|PDB:3S24}.
SQ   SEQUENCE   597 AA;  68557 MW;  51CEEC1B190603DE CRC64;
     MAHNKIPPRW LNCPRRGQPV AGRFLPLKTM LGPRYDSQVA EENRFHPSML SNYLKSLKVK
     MGLLVDLTNT SRFYDRNDIE KEGIKYIKLQ CKGHGECPTT ENTETFIRLC ERFNERNPPE
     LIGVHCTHGF NRTGFLICAF LVEKMDWSIE AAVATFAQAR PPGIYKGDYL KELFRRYGDI
     EEAPPPPLLP DWCFEDDEDE DEDEDGKKES EPGSSASFGK RRKERLKLGA IFLEGVTVKG
     VTQVTTQPKL GEVQQKCHQF CGWEGSGFPG AQPVSMDKQN IKLLDLKPYK VSWKADGTRY
     MMLIDGTNEV FMIDRDNSVF HVSNLEFPFR KDLRMHLSNT LLDGEMIIDR VNGQAVPRYL
     IYDIIKFNSQ PVGDCDFNVR LQCIEREIIS PRHEKMKTGL IDKTQEPFSV RNKPFFDICT
     SRKLLEGNFA KEVSHEMDGL IFQPTGKYKP GRCDDILKWK PPSLNSVDFR LKITRMGGEG
     LLPQNVGLLY VGGYERPFAQ IKVTKELKQY DNKIIECKFE NNSWVFMRQR TDKSFPNAYN
     TAMAVCNSIS NPVTKEMLFE FIDRCTAASQ GQKRKHHLDP DTELMPPPPP KRPRPLT
//
